Avastin is a vegf inhibitor approved for the treatment of metastatic colorectal cancer non squamous non small cell lung cancer metastatic kidney cancer renal cell carcinoma recurrent or metastatic cervical cancer recurrent glioblastoma brain cancer and ovarian fallopian tube or primary peritoneal cancer mvasi is a biosimilar medication. Avastin is designed to block a protein called vascular endothelial growth factor or vegf normal cells make vegf but some cancer cells especially kidney cancer cells make too much vegf blocking vegf may prevent the growth of new blood vessels including normal blood vessels and blood vessels that feed tumors. Avastin r bevacizumab is approved to treat metastatic colorectal cancer or mcrc for first or second line treatment in combination with intravenous 5 fluorouracil based chemotherapy avastin is also approved as a second line treatment when used with fluoropyrimidine based combined with irinotecan or oxaliplatin chemotherapy after cancer progresses following a first line treatment . Bevacizumab injection is given with other medicines to treat patients with metastatic a cancer that has spread carcinoma of the colon or rectumthis medicine is also used to treat a certain type of metastatic lung cancer called nonsquamous non small cell lung cancer and a certain type of brain tumor called glioblastoma bevacizumab is a substance that helps the body fight cancer
How it works:
1. Register Trial Account.
2. Download The Books as you like ( Personal use )